Abstract
The organophosphate cholinesterase inhibitor paraoxon is hydrolysed by serum paraoxonase/arylesterase. A genetic polymorphism of paraoxonase (PON) activity which determines high versus low paraoxon hydrolysis in human populations, may determine sensitivity to parathion poisoning. We demonstrate that arginine at position 192 specifies high activity PON whereas a glutamine specifies the low activity variant. Allele–specific probes or restriction enzyme analysis of amplified DNA allow for the genotyping of individuals. PON maps to chromosome 7q21–22, proximal to the cystic fibrosis gene, in agreement with previous genetic linkage studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gage, J.C. A cholinesterase inhibitor derived from O,O-diethyl O-p-nitrophenyl thiophosphate in vivo. Biochem. J. 54, 426–430 (1954).
Diggle, W.M. & Gage, J.C. Cholinesterase inhibition by parathion in vivo. Nature 168, 998 (1951).
Davidson, A.N. The conversion of schradan (OMPA) and parathion into inhibitors of cholinesterase by mammalian liver. Biochem. J. 61, 203–209 (1955).
Poore, R.E. & Neal, R.A. Evidence for extrahepatic metabolism of parathion. Toxicol. Appl. Pharmacol. 23, 759–768 (1972).
Aldridge, W.N. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E 600) and its identity with the A-esterase of mammalian sera. Biochem. J. 53, 117–124 (1953).
Mackness, M.I. & Walker, C.H. Partial purification and properties of sheep serum ‘A’ esterases. Biochem. Pharmacol. 32, 2291–2296 (1983).
Krisch, K. Enzymatische hydrolyse von Diäthyl-p-nitrophenylphosphat (E 600) durch menschliches serum. Z klin. Chem. u. klin. Biochem. 6, 41–45 (1968).
Geldmacher-von Mallinckrodt, M., Rabast, U. & Lindorf, H.H. Unterscheidliche reaktion menschlicher serum-cholinesterasen mit E600 (O,O-diäthyl-O-(p-nitrophenyl)-phosphat. Arch. Toxikol. 25, 223–228 (1969).
Zech, R. & Zurcher, K. Organophosphate splitting enzymes in different mammals. Comp. Biochem. Physiol. 48B, 427–433 (1974).
Furlong, C.E., Richter, R.J., Seidel, S.J. & Motulsky, A. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. hum. Genet. 43, 230–238 (1988).
Playfer, J.R., Eze, L.C., Bullen, M.F. & Evans, D.A.P. Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J. med. Genet. 13, 337–342 (1976).
Geldmacher-von Mallinckrodt, M. et al. Genetisch determinierter polymorphismus der menschlichen serum-paraoxonase (EC 3.1.1.2) Humangenetik 17, 331–335 (1973).
Mueller, R.F. et al. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. Am. J. Hum. Genet. 35, 393–408 (1983).
Eiberg, H. & Mohr, J. Genetics of paraoxonase. Ann. hum. Genet. 45, 323–330 (1981).
Eckerson, H.W., Whyte, C.M. & LaDu, B.N. The human serum paraoxonase/ arylesterase polymorphism. Am. J. hum. Genet. 35, 1126–1138 (1983).
Ortigoza-Ferado, J., Richter, R.J., Hornung, S., Motulsky, A.G. & Furlong, C.E. Paraoxon hydrolysis in human serum albumin mediated by a genetically variable arylesterase and albumin. Am. J. hum. Genet. 36, 295–305 (1984).
Geldmacher-von Mallinckrodt, M. & Diepgen, T.L. The polymorphism of the human serum paraoxonase. Toxicol. Environ. Chem. 14, 165–181 (1987).
Eckerson, H.W., Romson, J., Whyte, C. & LaDu, B. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am. J. hum. Genet. 35, 214–227 (1983).
Smolen, A., Eckerson, H.W., Gan, K.N., Hailat, N. & LaDu, B.N. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metab. Dispos. 19, 107–112 (1991).
Geldmacher-von Mallinckrodt, M. & Diepgen, T.L. The human serum paraoxonase - polymorphism and specificity. Toxicol. Environ. Chem. 18, 79–196 (1988).
Butler, E.G., Eckerson, H.W. & LaDu, B.N. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit. Drug Metab. Dispos. 13, 640–645 (1985).
Costa, L.G. et al. Species differences in serum paraoxonase correlate with sensitivity to paraoxon toxicity. in Toxicology of Pesticides: Experimental, Clinical and Regulatory Aspects (ed. Costa, L. G.) 263–266 (Springer, Berlin, 1987).
McCollister, S., Kociba, R.J., Humiston, C.G., McCollister, D.D. & Gehring, P.J. Studies of the acute and long-term oral toxicity of chlorpyrifos (O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl) phosphorothioate) Cosmet. Toxicol. 12, 45–61 (1974).
Furlong, C.E. et al. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal. Biochem. 180, 242–247 (1989).
Main, A.R. The role of A-esterase in the acute toxicity of paraoxon, TEPP, and parathion. Canad. J. Biochem. Physiol. 34, 197–216 (1956).
Costa, L.G. et al. Serum paraoxonase and its influence on paraoxon and chlorpyrifos oxon toxicity in rats. Toxicol. Appl. Pharmacol. 103, 66–76 (1990).
Eiberg, H., Mohr, J., Schmiegelow, K., Nielsen, L.S. & Williamson, R. Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny. Clin. Genet. 28, 265–271 (1985).
Schmiegelow, K. et al. Linkage between the loci for cystic fibrosis and paraoxonase. Clin. Genet. 29, 374–377 (1986).
Knowlton, R.G. et al. A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature 318, 380–382 (1985).
White, R. et al. A closely linked genetic marker for cystic fibrosis. Nature 318, 382–384 (1985).
Wainwright, B.J. et al. Localization of cystic fibrosis to human chromosome 7cen-q22. Nature 318, 384–385 (1985).
Rommens, J.M. et al. Identification and regional localization of DNA markers on chromosome 7 for the cloning of the cystic fibrosis gene. Am. J. hum. Genet. 43, 645–663 (1988).
Beaudet, A. et al. Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am. J. hum. Genet. 39, 681–693 (1986).
Tsui, L.-C. et al. Genetic analysis of cystic fibrosis using linked DNA markers. Am. J. hum. Genet. 39, 720–728 (1986).
Rommens, J.M. et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059–1066 (1989).
Riordan, J.R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989).
Kerem, B.-S. et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073–1080 (1989).
Collins, F.S. Cystic fibrosis: molecular biology and therapeutic implications. Science 256, 774–779 (1992).
Hassett, C. et al. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 30, 10141–10149 (1991).
Furlong, C.E., Richter, R.J., Chapline, C. & Crabb, J. Purification of rabbit and human serum paraoxonase. Biochemistry 30, 10133–10140 (1991).
McElveen, J. et al. Distribution of paraoxon hydrolytic activity in the serum of patients following myocardial infarction. Clin. Chem. 32, 671–673 (1986).
Mackness, M.I., Arrol, S. & Durrington, P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286, 152–154 (1991).
Saha, N., Roy, A.C., Teo, S.H., Tay, J.S.H. & Ratnam, S.S. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin. Genet. 40, 277–282 (1991).
Poncz, M. et al. Construction of human gene libraries from small amounts of peripheral blood. Analysis of β-like globin genes. Hemoglobin 6, 27–36 (1982).
Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487–491 (1988).
Vogelstein, B. & Gillespie, D. Preparative and analytical purification of DNA from agarose. Proc. natn. Acad. Sci. U.S.A. 76, 615–619 (1979).
Marth, J.D. et al. Localization of a lymphocyte-specific protein tyrosine kinase gene (Ick) at a site of frequent chromosomal abnormalities in human lymphomas. Proc. natn. Acad. Sci. U.S.A. 83, 7400–7407 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Humbert, R., Adler, D., Disteche, C. et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3, 73–76 (1993). https://doi.org/10.1038/ng0193-73
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0193-73
This article is cited by
-
Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations
BMC Medical Genomics (2024)
-
Health consequences of exposure to aircraft contaminated air and fume events: a narrative review and medical protocol for the investigation of exposed aircrew and passengers
Environmental Health (2023)
-
Total impact of oxidative stress genes on cardiovascular events—a 7-year follow-up study
Journal of Applied Genetics (2023)
-
Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease
Scientific Reports (2023)
-
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
BMC Infectious Diseases (2021)